- Products
Disease models

Pathological ECM changes drive disease progression by regulating cell–matrix interactions. Human diseased ECM substrates, including fibrotic liver and lung ECMs, enable clinically-relevant, high-fidelity disease modeling predictive of human disease biology.


Related Resources

Application Note: Accelerating Antifibrotic Drug Development with Human Fibrotic Liver ECM Substrates

Application Note: Accelerating Antifibrotic Drug Development with Human Fibrotic Lung ECM Substrates

Publication: Fibrotic Human Lung Extracellular Matrix as a Disease-Specific Substrate for Models of Pulmonary Fibrosis (2019)

Poster: Fibrotic Liver Extracellular Matrix Substrates for 3D in-vitro Models of Human Liver Fibrosis

Poster: Fibrotic Lung Extracellular Matrix Substrates for 3D in-vitro Models of Human Pulmonary Fibrosis